Mesenchymal Stem Cells-based Cell-free Therapy Targeting Neuroinflammation.

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Neuroinflammation is a key factor in neurodegenerative diseases (NDDs).
• Peripheral inflammation often precedes symptomatic onset in NDDs.
• The interplay between peripheral and central nervous system inflammation is critical in NDD pathogenesis.

Purpose of the Study:

• To review recent advances in understanding neuroinflammation in NDDs.
• To highlight the roles of microglia and astrocytes in neuroinflammation.
• To explore mesenchymal stem cell-based cell-free therapy for NDDs.

Main Methods:

• Review of scientific literature from the past three years.
• Focus on genetic elements and biochemical mechanisms of neuroinflammation.
• Analysis of mesenchymal stem cell-based cell-free therapy strategies.

Main Results:

• Identification of key cellular players (microglia, astrocytes) and inflammatory processes.
• Evidence for peripheral inflammation preceding NDD symptoms.
• Demonstration of mesenchymal stem cell-based cell-free therapy's potential to modulate neuroinflammation.

Conclusions:

• Mesenchymal stem cell-based cell-free therapy offers a novel approach to NDD treatment.
• This therapy targets neuroinflammation by regulating immune cells and inflammatory pathways.
• The approach emphasizes enhanced delivery and modulation of the immune system for NDD management.